BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21043553)

  • 1. Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life.
    Bushnell DM; Martin ML; Moore KA; Richter HE; Rubin A; Patrick DL
    Curr Med Res Opin; 2010 Dec; 26(12):2745-55. PubMed ID: 21043553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding.
    Lukes AS; Baker J; Eder S; Adomako TL
    Womens Health (Lond); 2012 Sep; 8(5):503-11. PubMed ID: 22934724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding.
    O'Brien SH; Saini S; Ziegler H; Christian-Rancy M; Ahuja S; Hege K; Savelli SL; Vesely SK
    J Pediatr Adolesc Gynecol; 2019 Jun; 32(3):305-311. PubMed ID: 30731217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The menstrual bleeding questionnaire: development and validation of a comprehensive patient-reported outcome instrument for heavy menstrual bleeding.
    Matteson KA; Scott DM; Raker CA; Clark MA
    BJOG; 2015 Apr; 122(5):681-9. PubMed ID: 25615842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
    Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
    Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.
    Lukes AS; Moore KA; Muse KN; Gersten JK; Hecht BR; Edlund M; Richter HE; Eder SE; Attia GR; Patrick DL; Rubin A; Shangold GA
    Obstet Gynecol; 2010 Oct; 116(4):865-875. PubMed ID: 20859150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid therapy for heavy menstrual bleeding.
    Lumsden MA; Wedisinghe L
    Expert Opin Pharmacother; 2011 Sep; 12(13):2089-95. PubMed ID: 21767224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid.
    Goshtasebi A; Moukhah S; Gandevani SB
    Arch Gynecol Obstet; 2013 Nov; 288(5):1055-60. PubMed ID: 23595582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.
    Lukes AS; Muse K; Richter HE; Moore KA; Patrick DL
    Curr Med Res Opin; 2010 Nov; 26(11):2673-8. PubMed ID: 20942615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytics for heavy menstrual bleeding.
    Lethaby A; Farquhar C; Cooke I
    Cochrane Database Syst Rev; 2000; (4):CD000249. PubMed ID: 11034679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of methods to measure menstrual blood loss.
    Magnay JL; O'Brien S; Gerlinger C; Seitz C
    BMC Womens Health; 2018 Aug; 18(1):142. PubMed ID: 30134884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding.
    Lukes AS; Kouides PA; Moore KA
    Womens Health (Lond); 2011 Mar; 7(2):151-8. PubMed ID: 21410342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
    Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis.
    Pattison H; Daniels JP; Kai J; Gupta JK
    BJOG; 2011 Nov; 118(12):1528-31. PubMed ID: 21790952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral modified-release tranexamic acid for heavy menstrual bleeding.
    Hrometz SL
    Ann Pharmacother; 2012; 46(7-8):1047-53. PubMed ID: 22811348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Psychometric Validation of a Screening Questionnaire to Detect Excessive Menstrual Blood Loss That Interferes in Quality of Life: The SAMANTA Questionnaire.
    Calaf J; Cancelo MJ; Andeyro M; Jiménez JM; Perelló J; Correa M; Parera N; Lete LI; Calvo A; Doval JL; Duarte R; García JL; Colomé C
    J Womens Health (Larchmt); 2020 Jul; 29(7):1021-1031. PubMed ID: 32580622
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifibrinolytics in women with menorrhagia.
    Philipp CS
    Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evaluation of safety and health-related quality of life in women with heavy menstrual bleeding treated with oral tranexamic acid.
    Muse K; Lukes AS; Gersten J; Waldbaum A; Mabey RG; Trott E
    Womens Health (Lond); 2011 Nov; 7(6):699-707. PubMed ID: 21867401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.